Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fesoterodine fumarate SR in overactive bladder (Phase III, China)
CTR20231909Phase 3Completed
- Sponsor
- Chenxin Pharmaceutical
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fesoterodine in overactive bladder (OAB), sponsored by Chenxin Pharmaceutical. Started Jun 2023; status: completed.
02
Drugs
fesoterodine
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on CTR20231909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231909.